The impact of COVID-19 on medication adherence in a rheumatoid (BRAGGSS) and psoriatic arthritis (OUTPASS) UK cohort

Abstract

Suboptimal treatment adherence has been reported in patients with arthritic diseases; is associated with psychological factors, including anxiety; and correlates with future treatment response.1,2 During the coronavirus disease 2019 (COVID-19) pandemic, patients who identified as clinically extremely vulnerable, including people prescribed ≥ 2 immunosuppressives, were advised to shield and continue treatment unless they developed COVID-19 symptoms.

Metadata

Item Type:	Article
Authors/Creators:	Curry, PDK Chinoy, H Jani, M Plant, D Hyrich, KL Morgan, AW https://orcid.org/0000-0003-1109-624X Wilson, AG Isaacs, JD Morris, AP Barton, A Bluett, J
Copyright, Publisher and Additional Information:	© 2023 The Journal of Rheumatology. This is an author produced version of an article published in The Journal of Rheumatology Uploaded in accordance with the publisher's self-archiving policy.
Dates:	Published: 1 July 2023 Published (online): 15 June 2023 Accepted: 1 May 2023
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:	Funder Grant number MRC (Medical Research Council) R116825 NIHR National Inst Health Research NIHR202395
Depositing User:	Symplectic Publications
Date Deposited:	05 May 2023 09:47
Last Modified:	27 Jul 2023 02:46
Status:	Published
Publisher:	Journal of Rheumatology
Identification Number:	10.3899/jrheum.2022-1277
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:198893

CORE (COnnecting REpositories)

The impact of COVID-19 on medication adherence in a rheumatoid (BRAGGSS) and psoriatic arthritis (OUTPASS) UK cohort

Abstract

Metadata

Download

Accepted Version

Export

Statistics